CAMBRIDGE, Mass.--(BUSINESS WIRE)--OmniGuide, Inc., a commercial stage medical device company, today announced that it has appointed Tracy Campbell Accardi as its Chief Technology Officer. Ms. Accardi is a seasoned medical device and diagnostics executive with a proven record of building global, high-performance teams that deliver innovative medical devices and diagnostic equipment. She has over 20 years of experience in the medical device industry, during which time she has developed impressive leadership abilities in addition to a keen knowledge of her profession.
"OmniGuide has developed a truly innovative technology that addresses critical clinical needs in the advanced surgical energy device market. The delivery of CO2 laser energy through a flexible fiber has the potential to significantly enhance clinical outcomes for patients and improve the operating room experience for surgeons. I am excited to work with our customers and the OmniGuide team to deliver enhanced surgical solutions based on precision access and control," said Ms. Accardi.
Ms. Accardi most recently served as vice president of global research and development for the Vascular Therapies division of Covidien, a world leader in medical devices. In that capacity, Ms. Accardi oversaw a team of 140+ engineers in the United States and Japan, and led teams in the development of acute and chronic dialysis catheters, vascular compression devices, pharmaco-mechanical thrombolysis treatment catheters and vein ablation catheters.
Ms. Accardi has also held executive level positions at Johnson & Johnson, Philips Healthcare and GE Healthcare. At each of these companies, she led international teams of engineers and scientists to develop cutting-edge products and therapies in the neurovascular and cardiovascular spaces.
Ms. Accardi graduated from Carnegie Mellon University with a dual bachelor’s degree in mechanical engineering and engineering and public policy. She also has a Master of Science in mechanical engineering from the Rensselaer Polytechnic Institute.
Currently based in Boston, Ms. Accardi sits on the board of “A Better Chance”, a nonprofit committed to the education of academically talented and promising young women of color from underserved communities.
"We are excited to have Tracy take on this leadership role in OmniGuide as we further develop innovative, market-leading surgical products in minimally invasive surgery. Tracy brings a highly relevant set of experiences that will positively influence our growth strategy," said Scott Flora.
OmniGuide, Inc. is a leader in the development and marketing of advanced surgical energy solutions for minimally invasive surgery that improve precision, access and control. OmniGuide’s products are sold under the BeamPath® brand and are clinically targeted for superior clinical outcomes in Gynecology, ENT and Neurosurgery. The Company distributes its products in the U.S. through a direct sales force and in Europe through distribution partners. OmniGuide is committed to developing products that improve and expand surgical treatment options, enhance clinical outcomes, and reduce treatment complexity and cost.
Additional information about OmniGuide may be found at www.omni-guide.com.